Disease | intrahepatic cholangiocarcinoma |
Phenotype | C0011847|diabetes |
Sentences | 1 |
PubMedID- 25980580 | Although we acknowledge that the current study does not address the efficacy of metformin against cancer cell models naturally bearing clinically relevant idh1 mutations, our findings provide a direct mechanistic link to the association between metformin use and a significant reduction in incidence of intrahepatic cholangiocarcinoma (ihcc) in patients with diabetes [87]. |
Page: 1